ERO1B and pancreatic adenocarcinoma: After validation of a subgroup of DEGs by using an additional pancreatic adenocarcinoma dataset, we found that GJB2 were upregulated and ERO1LB downregulated in malignant tissues than in normal pancreatic tissues.